Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression

BACKGROUND: Benralizumab can be utilized as add-on biological treatment of severe eosinophilic asthma. However, so far only a few real-life studies have been published with regard to the use of this anti-IL-5 receptor humanized monoclonal antibody. OBJECTIVE: The primary aim of this multicenter obse...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Asthma Allergy
Autors principals: Pelaia, Corrado, Crimi, Claudia, Benfante, Alida, Caiaffa, Maria Filomena, Calabrese, Cecilia, Carpagnano, Giovanna Elisiana, Ciotta, Domenico, D’Amato, Maria, Macchia, Luigi, Nolasco, Santi, Pelaia, Girolamo, Pellegrino, Simona, Scichilone, Nicola, Scioscia, Giulia, Spadaro, Giuseppe, Valenti, Giuseppe, Vatrella, Alessandro, Crimi, Nunzio
Format: Artigo
Idioma:Inglês
Publicat: Dove 2021
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7910091/
https://ncbi.nlm.nih.gov/pubmed/33654413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JAA.S297273
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars